Formulation Insights, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Int J Pharm. 2010 Nov 30;401(1-2):51-9. doi: 10.1016/j.ijpharm.2010.09.009. Epub 2010 Sep 19.
High concentrations of dissolved sugars can accelerate in vitro drug release in certain hydroxypropyl methylcellulose (HPMC) matrices (Williams et al., 2009). This study investigated the potential for common formulation variables to modulate sucrose sensitivity, and explored if more resistant formulations could be designed. In a model matrix containing 30% HPMC (Methocel™ K4M), the inclusion of sugar as a tablet diluent was a key factor. Lactose:microcrystalline cellulose mixtures, dextrose and d-xylose all produced highly swollen, erodible matrices in 0.7M sucrose (37°C), which collapsed and rapidly released remaining drug after 1-4h. This suggests internal and external sugars combine to disrupt the diffusion barrier properties of the gel layer. In contrast, matrices containing microcrystalline cellulose as the sole diluent provided extended release for 10h. Small particle size (<63μm) and high or low viscosity HPMC (Methocel™ K100M or K100LV) also improved sugar resistance. Knowledge of these variables allowed a significantly more resistant HPMC matrix to be designed which provided extended release for >16h in 0.9M sucrose. By judicious selection of excipient properties, the tolerance of HPMC matrices to high sucrose environments can be significantly improved.
高浓度的溶解糖可以加速某些羟丙基甲基纤维素(HPMC)基质中的体外药物释放(Williams 等人,2009 年)。本研究调查了常见制剂变量调节蔗糖敏感性的潜力,并探讨了是否可以设计更耐抗性的制剂。在含有 30%HPMC(Methocel K4M)的模型基质中,糖作为片剂稀释剂的包含是一个关键因素。乳糖:微晶纤维素混合物、葡萄糖和木糖在 0.7M 蔗糖(37°C)中均产生高度溶胀、可侵蚀的基质,在 1-4 小时后,这些基质坍塌并迅速释放剩余的药物。这表明内部和外部糖结合起来破坏了凝胶层的扩散屏障特性。相比之下,仅含有微晶纤维素作为唯一稀释剂的基质在 10 小时内提供了延长的释放。小粒径(<63μm)和高或低粘度的 HPMC(Methocel K100M 或 K100LV)也提高了耐糖性。对这些变量的了解允许设计出一种更耐抗性的 HPMC 基质,该基质在 0.9M 蔗糖中提供超过 16 小时的延长释放。通过明智地选择赋形剂特性,可以显著提高 HPMC 基质对高蔗糖环境的耐受性。